Skip to main content

MedTechLabs researchers get funding from Vinnova

New diagnostic solutions based on AI for breast cancer pathology

Mattias Rantalainen och Johan Hartman, Karolinska Institutet
Mattias Rantalainen och Johan Hartman, Karolinska Institutet
Published Sep 29, 2021

MSEK 20 granted for clinical implementation. Project conducted in participation with industry companies, regions and Swedish Breast Cancer Association.

Great news! MedTechLabs researchers Mattias Rantalainen, Johan Hartman and colleagues at Karolinska Institute has been granted MSEK 20 from Vinnova for their clinical implementation of AI on breast cancer pathology. The total Vinnova investment of MSEK 323 in innovation environments in precision health will pave the way for a more preventive, accurate and equal health care and contribute to strengthening Sweden as a life science nation. Read more  (in Swedish)